Professor of Medicine, University Nebr College of Medicine
Pulmonology
Dr. Stephen I. Rennard, MD
|
|
Give Review
Stephen I. Rennard works in the field of Pulmonology. He attended Baylor College of Medicine. He received 2 awards: "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Stephen I. Rennard, MD is also a published physician. He has 98 publication published. The most recent publication is: Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. He is registered with Medicare and accepts Medicare payments.
Publications
- Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.
- Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.
- Continuous fat-free mass decline in COPD: fact or fiction?
- A genome-wide analysis of the response to inhaled β2-agonists in Chronic obstructive pulmonary disease.
- Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis.
- Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
- CXCR2 Antagonist MK-7123-A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
- Effect of culture conditions on microRNA expression in primary adult control and COPD Lung fibroblasts in vitro.
- Prostaglandin E2 switches from a stimulator to an inhibitor of cell migration after epithelial-to-mesenchymal transition.
- Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers.
- Radiological correlates and clinical implications of the paradoxical Lung function response to β2 agonists: an observational study.
- Location, location, location: studying anatomically comparable airways is highly relevant to understanding COPD.
- Fibroblasts That Resist Cigarette Smoke-induced Senescence Acquire Pro-fibrotic Phenotypes.
- Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels.
- Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and In...
- Common Genetic Variants Associated with Resting Oxygenation in Chronic Obstructive Pulmonary Disease.
- An Aberrant Leukotriene A4 Hydrolase-PGP Pathway in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
- Chronic Obstructive Pulmonary Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.
- Sphingosylphosphorylcholine Induces α-Smooth Muscle Actin Expression in Human Lung Fibroblasts and Fibroblasts Mediated Gel Contraction Via S1P2 receptor and Rho/Rho-K...
- Quantitative Computed Tomographic Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
- Reprogramming of COPD Lung fibroblasts through formation of induced pluripotent stem cells (iPSCs).
- Reply: correctly defining criteria for diagnosing Chronic obstructive pulmonary disease matters.
- ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Pati...
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).
- Systemic sRAGE is a Biomarker of Emphysema and Associated with AGER Genetic Variants in COPD Patients.
- Vitamin D Modulates PGE2 Synthesis and Degradation in Human Lung Fibroblasts.
- Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells.
- Vitamin D, vitamin D binding protein, Lung function and structure in COPD.
- The COPD Biomarker Qualification Consortium (CBQC).
- Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation.
- Patient-reported Outcome (PRO) Measures for Clinical Trials of COPD: The EXACT and E-RS.
- Phosphodiesterase 4 Inhibition Augments Human Lung Fibroblast VEGF Production Induced by PGE2.
- Diet and vitamin D as risk factors for Lung impairment and COPD.
- What is Chronic obstructive pulmonary disease anyway?
- Smad3 Mediates Cigarette Smoke Extract (CSE) Induction of VEGF Release by Human Fetal Lung Fibroblasts.
- Long-term safety study of infliximab in moderate-to-severe Chronic obstructive pulmonary disease.
- Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells.
- Dissecting direct and indirect genetic effects on Chronic obstructive pulmonary disease (COPD) susceptibility.
- A randomised trial of fluticasone furoate/vilanterol (50/25 ?g; 100/25 ?g) on Lung function in COPD.
- Inflammation in COPD: implications for management.
- Systemic Steroid Exposure is Associated with Differential Methylation in Chronic Obstructive Pulmonary Disease.
- Attenuation of Inhibitory PGE2 Signaling in Human Lung Fibroblasts is Mediated by PDE4.
- The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair.
- Development and Preclinical Efficacy of Novel Transforming Growth Factor-?1 siRNAs for Pulmonary Fibrosis.
- PGE2 Stimulates VEGF Production through the EP2 Receptor in Cultured Human Lung Fibroblasts.
- Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: A cross-study analysis.
- Introduction: Tenth Lund COPD Symposium.
- To use or not to use: clinical decision making in the face of uncertainty.
- COPD Heterogeneity: What This Will Mean in Practice.
- Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of Chronic obstructive pulmonary disease.
- Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial.
- Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes.
- Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
- Efficacy and safety of once-daily aclidinium in Chronic obstructive pulmonary disease.
- Hypothesis: in COPD, a pound of cure may be better than an ounce of prevention.
- IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells.
- Evaluation of exhaled breath condensate pH as a biomarker for COPD.
- Long-term Safety and Efficacy of Indacaterol, a Novel Long-acting {beta}2-Agonist, in Subjects with COPD: a Randomized, Placebo-controlled Study.
- Prostaglandin Eâ‚‚ inhibits human Lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
- Hepatic growth factor (HGF) inhibits cigarette smoke extract induced apoptosis in human bronchial epithelial cells.
- Long-term cigarette smoke exposure in a mouse model of ciliated epithelial cell function.
- 뱉-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
- Reduced miR-146a increases prostaglandin Eâ‚‚in Chronic obstructive pulmonary disease fibroblasts.
- Chronic obstructive pulmonary disease phenotypes: the future of COPD.
- Multistudy fine mapping of chromosome 2q identifies XRCC5 as a Chronic obstructive pulmonary disease susceptibility gene.
- Introduction: Ninth Lund COPD Symposium.
- Can increased understanding of the role of lung development and aging drive new advances in Chronic obstructive pulmonary disease?
- Chicken soup inhibits neutrophil chemotaxis in vitro. 2000.
- PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
- Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.
- MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis.
- C-reactive protein modulates human Lung fibroblast migration.
- Natural histories of Chronic obstructive pulmonary disease.
- Lessons from multidisciplinary cross-fertilization: Chronic obstructive pulmonary disease, lung cancer, and heart disease.
- Foreword: "The Big Three".
- Sphingosine 1-phosphate potentiates human Lung fibroblast chemotaxis through the S1P2 receptor.
- The many "small COPDs": COPD should be an orphan disease.
- Lung fibroblast repair functions in patients with Chronic obstructive pulmonary disease are altered by multiple mechanisms.
- Prostacyclin analogs stimulate VEGF production from human Lung fibroblasts in culture.
- PKCdelta mediates thrombin-augmented fibroblast-mediated collagen gel contraction.
- Update on smoking cessation interventions for the Primary care physician. Introduction.
- Knowledge and beliefs about genetics and smoking among visitors and staff at a health care facility.
- IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
- Exacerbation-free COPD: a goal too far?
- Cultured lung fibroblasts from ovalbumin-challenged "Asthmatic" mice differ functionally from normal.
- Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway.
- The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6.
- Comment: Oral varenicline for smoking cessation.
- Enhancing COPD management in primary care settings.
- Prostaglandin E(2) protects human Lung fibroblasts from cigarette smoke extract-induced apoptosis via EP(2) receptor activation.
- Thrombin and TNF-alpha/IL-1beta synergistically induce fibroblast-mediated collagen gel degradation.
- Cigarette smoke inhibits alveolar repair: a mechanism for the development of Emphysema.
- Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and ...
- Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure.
- Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification.
- Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis.
- Smad3 mediates TGF-beta1-induced collagen gel contraction by human Lung fibroblasts.
Schools
Baylor University
Barnes Jewish Hospital
Procedures Preformed
- Bronchoscopy
- Thoracentesis
Conditions Treated
- Acidosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Washington University - Barnes-Jewish Hospital -
Baylor College of Medicine
Drug Facts
| NPI NUMBER | 1023068053 | |
| NPPES Provider LastName | RENNARD | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023068053 |
| Last Name Of The Provider | RENNARD |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Tammy O. Wichman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin B. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard S. Yates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marlin G. Stahl, MD
This Doctor is OpenDoctor Recommended.
|